Navigation Links
Everist Genomics Announces Acquisition of Angiologix, Inc.
Date:10/31/2011

ANN ARBOR, Mich., Oct. 31, 2011 /PRNewswire/ -- Everist Genomics, a rapidly growing personalized medicine company developing and commercializing innovative diagnostics and prognostics, announced today that it has successfully completed acquisition of 100% of the shares of Angiologix, Inc., the developer of the AngioDefender™ diagnostic device for assessing endothelial function.  Endothelial cell dysfunction is a key biomarker of early-stage atherosclerosis and CVD; it is also the earliest detectable sign of atherosclerosis. (1)

(Photo: http://photos.prnewswire.com/prnh/20111031/NY96250 )

(Logo: http://photos.prnewswire.com/prnh/20110110/NY26865LOGO)

AngioDefender is a highly accurate and low-cost tool designed to allow physicians to assess endothelial function -- a key indicator of blood vessel health.  Clinical syndromes such as stable and unstable angina, acute myocardial infarction, claudication, and stroke relate, in part, to a loss of endothelial control of vascular tone, thrombosis, and the composition of the vascular wall. (2) Such a tool could aid in the diagnosis of early stage atherosclerosis and cardiovascular disease (CVD) in asymptomatic patients.  Clinical studies (3) show that pharmacological and life style interventions are effective in treating endothelial dysfunction; these interventions are also efficacious in treating CVD:Intervention/TreatmentEffect on Endothelial FunctionEffect on CVD EventsLipid-lowering therapyBeneficial

BeneficialSmoking cessationBeneficial

BeneficialExerciseBeneficial

BeneficialACE Inhibitors

Beneficial

BeneficialAngiotensin receptor blockers

Beneficial

BeneficialN-3 fatty acids

Beneficial

BeneficialGlycemic control in diabetes mellitus

Beneficial

BeneficialThe endothelium, a thin layer of cells that line the walls of every blood vessel, is
'/>"/>

SOURCE Everist Genomics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients
2. Everist Genomics Announces Worldwide Availability of OncoDefender™-CRC
3. Genetics Squared Changes Name To Everist Genomics
4. Synthetic Genomics Vaccines, Inc. Hires Vaccine Executive Sammy J. Farah as President
5. Cancer Game Changers: Genomics, Smarter Medicine, Care Coordination Comprise Medcos Advanced Oncology Solutions™
6. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
7. CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study
8. Rosetta Genomics Announces Issuance of Additional U.S. Patent
9. WaferGen Appoints World-Renowned Clinical Genomics Cancer Researcher Dr. Arul M. Chinnaiyan to Scientific Advisory Board
10. NeoGenomics Awarded $374,000 in R&D Grants from the US Government
11. NeoGenomics Schedules its Q3 2010 Earnings Release for October 28, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... N.J. and FARMINGTON, Conn. ... Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company ... of diseases with significant unmet medical need and ... on a private placement of 2,050,000 shares of ... purchase 24,949,325 shares of its common stock.  Funds ...
(Date:12/24/2014)... Dec. 23, 2014 Echo Therapeutics, Inc. ... company focused on skin permeation, continuous glucose monitoring ... W. Hollander has been appointed Chief Executive ... more than 20 years of experience in the ... most recently served as Vice President, Business Development, ...
(Date:12/24/2014)... December 24, 2014 ... Global Disposable Syringe Industry of 178 pages ... business intelligence library. The 2014 ... Industry is a professional and deep research ... overview analysis, the report introduces Disposable Syringe ...
Breaking Medicine Technology:Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... to need emergency room treatment or hospitalization when ... series to examine factors impacting patient response to ... of a new study presented at the 2009 ... Allergy and Immunology (AAAAI) show dramatic reductions in ...
... At the Health Industries Council meeting on March 11, ... health and behavioral sciences at the University of ... Health, announced new findings that indicate that mortality is ... reduced spending on health care have a direct effect ...
Cached Medicine Technology:New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 2New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 3New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 4Unemployment, Health Care Spending Affect Mortality 2
(Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
(Date:12/25/2014)... The short film “Color of Honor” by young ... a true 9/11 hero, Welles Remy Crowther. It has been ... hours of Nuremberg International Short Film Festival and the 8th ... screenwriter and director Luciana Lagana plays the mother of ... husband, Gregory Graham - Graham plays a heroic ...
(Date:12/25/2014)... Helen Harris’ RP (Retinitis Pigmentosa) International ... after an 8 year battle with breast cancer. ... in her home in Woodland Hills California after an ... , As the founder and volunteer President ... and championed many of today's greatest breakthroughs in restoring ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... children with complex chronic illnesses can receive effective, less expensive ... with easy access to a team of dedicated health care ... to become seriously ill and need either hospitalization or a ... an enhanced medical home clinic at the University of Texas ...
(Date:12/25/2014)... (HealthDay News) -- Among early stage breast cancer patients ... of one percent will eventually develop leukemia as a ... The finding comes from a review of more than ... and it suggests that the risk for developing treatment-related ... previously thought. "The frequency of bone marrow cancers ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... at a premium among Afghan couples, reports say. ... do scout around for sperm donors and invariably land ... never-ending conflicts, sparked by Islamist fervour that might ... such imbalances in turn could in turn lead to ...
... scientific review of a dozen patients who have received the ... technique is safe and may be effective at staving off ... of whom live on Long Island, are in advanced stages ... when they signed on for the experimental therapy. The study ...
... employed on the moon in the not too distant ... ,According toChester Spell, an associate professor of management at ... tomorrow - or, for that matter, the space stations ... health of employees working in isolation for extended periods. ...
... Purdue University researchers have begun the first phase of human ... designed in-house. ,The drug is based on ... university. The researchers say that it may help intercept and ... of people suffer from this devastating disease and treatment options ...
... against Human Cytomegalovirus (hCMV) infection and disease was developed by ... (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences. ... viral cause of birth defects and a serious problem in ... protect against infection by the virus, estimated to be present ...
... for testing and measuring xanthones. Preliminary results from ... indicate usage of the whole mangosteen fruit as ... ,XanGo, LLC, recognized creator of the ... the whole mangosteen fruit (Garcinia mangostana) through a ...
Cached Medicine News:Health News:Afghan Couple Turn to Indian Sperm Banks for Help 2Health News:Gene Therapy for Parkinsons Disease 2Health News:Ex-IITian-designed Alzheimer's Drug's Human Clinical Trials Begin 2Health News:New Vaccine for CMV Infection 2Health News:New Vaccine for CMV Infection 3Health News:New Technique to Measure Xanthone in Mangosteen 2Health News:New Technique to Measure Xanthone in Mangosteen 3
... Plate Shaker with Timer are designed to give ... & 384-well microplates. The on/off button, power supply ... the side of the unit. The speed knob ... for adjustment of speed from a minimum 950 ...
Microplate incubator shaker used in a variety of immunoassay and research procedures requiring microplates....
Multiparameter laser and arc lamp flow cytometer for all applications in immunology, microbiology, cell biology, pathology, hematology, lymphocyte dubset and cell analysis....
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
Medicine Products: